Skip to content

Advertisement

Open Peer Review Reports for: Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
19 Aug 2016 Submitted Original manuscript
2 Sep 2016 Author responded Author comments - Lin Shen
Resubmission - Version 2
2 Sep 2016 Submitted Manuscript version 2
9 Jan 2017 Reviewed Reviewer Report - Arjun Kalvala
6 Feb 2017 Reviewed Reviewer Report - Linara Gabitova
28 Feb 2017 Author responded Author comments - Lin Shen
Resubmission - Version 3
28 Feb 2017 Submitted Manuscript version 3
11 Mar 2017 Reviewed Reviewer Report - Linara Gabitova
18 Mar 2017 Reviewed Reviewer Report - Roberto Passera
10 Apr 2017 Author responded Author comments - Lin Shen
Resubmission - Version 4
10 Apr 2017 Submitted Manuscript version 4
11 Apr 2017 Reviewed Reviewer Report - Roberto Passera
12 Jul 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 5
12 Jul 2017 Submitted Manuscript version 5
18 Jul 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 6
18 Jul 2017 Submitted Manuscript version 6
29 Aug 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 7
29 Aug 2017 Submitted Manuscript version 7
3 Nov 2017 Author responded Author comments - Ruihua Xu
Resubmission - Version 8
3 Nov 2017 Submitted Manuscript version 8
Publishing
8 Dec 2017 Editorially accepted
22 Dec 2017 Article published 10.1186/s12885-017-3887-z

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement